FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384520239> ?p ?o ?g. }

• W4384520239 endingPage "106" @default.
• W4384520239 startingPage "98" @default.
• W4384520239 abstract "Backgrounds: Direct laryngoscopy and tracheal intubation are noxious stimuli that can provokeundesirable responses in the cardiovascular, respiratory and other physiologic system. These physiologicalchanges are well tolerated by healthy individuals. However, these changes may be detrimental or evenfatal in patients with coronary artery disease, hypertension, cerebrovascular disease, intracranialaneurysm, valvular heart disease.Many pharmacological techniques were introduced and evaluated either in the premedication or duringinduction to attenuate the hemodynamic pressor response to laryngoscopy and tracheal intubation, butresults were controversial. A drug that has analgesic properties, opioid sparing effects, possibly reducesopioid tolerance, relieves anxiety and is not associated with adverse effect would be an attractive adjuvant.Gabamimetic drug like gabapentin have been successfully used as oral premedication to attenuate pressorresponse during airway instrumentation, to decrease the preoperative anxiety and to reduce perioperativefentanyl consumption.In contrast, newer generation Gabamimetic drug pregabalin is effective in preventingneuropathic component of acute nociceptive pain of surgery and is several times more potent thangabapentin. Pregabalin is being used as oral premedicant in some studies but very few comparativestudies with gabapentin is present at time. So, there is a need to study the effectiveness of oral pregabalinin attenuating the hemodynamic response to laryngoscopy and intubation. If pregabalin is established asoral premedicant then it will bring a great benefit to peri-operative period with minimal cost. Objectives: To compare the efficacy of pregabalin and gabapentin in attenuation of laryngoscopy andintubation reflex (HTN & Tachycardia). Methods: This is hospital based randomized double-blind control study. Eighty patients, classified by (ASA)physical status category I-II, were randomized by card method in two groups of 40 patients each. The patientswere randomly allocated to receive oral Pregabalin 150mg (Group A) and Gabapentin 600mg tablet (Group B)1 hour prior to surgery. Before administration of the oral premedication, each patient’s baseline heart rate,systolic and diastolic blood pressure, mean arterial pressure and oxygen saturation were recorded by ananesthesiologist who was not enrolled into the study about the occurrence. In addition, to measure anxietyand sedation Ramsay Sedation Score was completed for each patient. All measurements were repeated beforeinduction. Grade 2 patient was selected. Systolic, diastolic and mean arterial blood pressure (SAP, DAP,MAP) and heart rate (HR), oxygen saturation (Spo2) was recorded after administration of IV anesthetics,immediately after intubation and cuff inflation, and 1, 3, 5 and 10 minutes after intubation. After trachealextubation the patients were monitored for 24 about the occurrence of any side effects, such as nausea,vomiting, dizziness, blurred vision, respiratory insufficiency, confusion and recorded if they were present. Result: Patients characteristics in respect of age, residence, other socio-demographic characteristics,ASA status and type of surgery were similar between the groups. Oral tablet Pregabalin150mg is moreeffective than tablet Gabapentin 600mg, in attenuation of intubation reflex. A single, oral dose of 150 mgof pregabalin premedication seems to be effective in attenuating the hemodynamic response to endotrachealintubation after the first attempt. Conclusion: Pregabalin 150 mg is a better alternative to Gabapentin 600 mg in attenuation of intubationreflex without major side effect. JBSA 2020; 33(2): 98-106" @default.
• W4384520239 created "2023-07-18" @default.
• W4384520239 creator A5029110929 @default.
• W4384520239 creator A5029664814 @default.
• W4384520239 creator A5057908531 @default.
• W4384520239 creator A5060654589 @default.
• W4384520239 creator A5075287843 @default.
• W4384520239 creator A5076294997 @default.
• W4384520239 creator A5092484527 @default.
• W4384520239 date "2020-07-31" @default.
• W4384520239 modified "2023-09-27" @default.
• W4384520239 title "Efficacy of pregabalin in attenuation of laryngoscopy and intubation reflex-A comparison with gabapentin" @default.
• W4384520239 doi "https://doi.org/10.3329/jbsa.v33i2.67531" @default.
• W4384520239 hasPublicationYear "2020" @default.
• W4384520239 type Work @default.
• W4384520239 citedByCount "0" @default.
• W4384520239 crossrefType "journal-article" @default.
• W4384520239 hasAuthorship W4384520239A5029110929 @default.
• W4384520239 hasAuthorship W4384520239A5029664814 @default.
• W4384520239 hasAuthorship W4384520239A5057908531 @default.
• W4384520239 hasAuthorship W4384520239A5060654589 @default.
• W4384520239 hasAuthorship W4384520239A5075287843 @default.
• W4384520239 hasAuthorship W4384520239A5076294997 @default.
• W4384520239 hasAuthorship W4384520239A5092484527 @default.
• W4384520239 hasBestOaLocation W43845202391 @default.
• W4384520239 hasConcept C142724271 @default.
• W4384520239 hasConcept C204787440 @default.
• W4384520239 hasConcept C2776468701 @default.
• W4384520239 hasConcept C2776608144 @default.
• W4384520239 hasConcept C2776888792 @default.
• W4384520239 hasConcept C2778029997 @default.
• W4384520239 hasConcept C2778300832 @default.
• W4384520239 hasConcept C2778716859 @default.
• W4384520239 hasConcept C2780820201 @default.
• W4384520239 hasConcept C42219234 @default.
• W4384520239 hasConcept C71924100 @default.
• W4384520239 hasConceptScore W4384520239C142724271 @default.
• W4384520239 hasConceptScore W4384520239C204787440 @default.
• W4384520239 hasConceptScore W4384520239C2776468701 @default.
• W4384520239 hasConceptScore W4384520239C2776608144 @default.
• W4384520239 hasConceptScore W4384520239C2776888792 @default.
• W4384520239 hasConceptScore W4384520239C2778029997 @default.
• W4384520239 hasConceptScore W4384520239C2778300832 @default.
• W4384520239 hasConceptScore W4384520239C2778716859 @default.
• W4384520239 hasConceptScore W4384520239C2780820201 @default.
• W4384520239 hasConceptScore W4384520239C42219234 @default.
• W4384520239 hasConceptScore W4384520239C71924100 @default.
• W4384520239 hasIssue "2" @default.
• W4384520239 hasLocation W43845202391 @default.
• W4384520239 hasOpenAccess W4384520239 @default.
• W4384520239 hasPrimaryLocation W43845202391 @default.
• W4384520239 hasRelatedWork W2125086625 @default.
• W4384520239 hasRelatedWork W2187552335 @default.
• W4384520239 hasRelatedWork W2575359423 @default.
• W4384520239 hasRelatedWork W2610814441 @default.
• W4384520239 hasRelatedWork W2625931765 @default.
• W4384520239 hasRelatedWork W2886279064 @default.
• W4384520239 hasRelatedWork W2902415101 @default.
• W4384520239 hasRelatedWork W4285816846 @default.
• W4384520239 hasRelatedWork W2184776254 @default.
• W4384520239 hasRelatedWork W2962244374 @default.
• W4384520239 hasVolume "33" @default.
• W4384520239 isParatext "false" @default.
• W4384520239 isRetracted "false" @default.
• W4384520239 workType "article" @default.